Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P61224
UPID:
RAP1B_HUMAN
Alternative names:
GTP-binding protein smg p21B
Alternative UPACC:
P61224; B2R5Z2; B4DQI8; B4DW74; B4DW94; P09526; Q502X3; Q5TZR4; Q6DCA1; Q6LES0
Background:
Ras-related protein Rap-1b, also known as GTP-binding protein smg p21B, plays a pivotal role in cellular processes. It exhibits intrinsic GTPase activity, essential for endothelial cell polarity, vascular lumen formation, and basal endothelial barrier function. Rap-1b's involvement in the localization of phosphorylated PRKCZ, PARD3, and TIAM1 to cell junctions underscores its significance in cellular signaling and structural organization.
Therapeutic significance:
Understanding the role of Ras-related protein Rap-1b could open doors to potential therapeutic strategies.